Testing effectiveness (Phase 2)Looking for participantsNCT07203001
What this trial is testing
A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease
Who this might be right for
Still´s Disease
Novartis Pharmaceuticals 20